Metagenomi, Inc. Common Stock

MGX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$78-$68-$44-$21
Dep. & Amort.$5$4$2$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$16$7$2$0
Change in WC-$60-$26$69$46
Other Non-Cash$7-$8$0-$1
Operating Cash Flow-$109-$91$30$24
Investing Activities
PP&E Inv.-$3-$10-$14-$3
Net Acquisitions$0$0$0$0
Inv. Purchases-$306-$208-$215-$71
Inv. Sales/Matur.$221$264$107$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$88$46-$122-$74
Financing Activities
Debt Repay.$0$0$0$30
Stock Issued$84$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1$240$10
Financing Cash Flow$84$1$240$40
Forex Effect$0$0$0$0
Net Chg. in Cash-$113-$45$147-$10
Supplemental Information
Beg. Cash$146$191$43$54
End Cash$33$146$191$43
Free Cash Flow-$112-$101$16$21
Metagenomi, Inc. Common Stock (MGX) Financial Statements & Key Stats | AlphaPilot